137 related articles for article (PubMed ID: 7050938)
21. [Complement system proteins and hypocomplement glomerulopathy. Acute post-streptococcal glomerulonephritis, membranoproliferative glomerulonephritis, and glomerulonephritis in system lupus erythematosus].
Popović-Rolović M; Maglajlić S; Radlović N
Srp Arh Celok Lek; 1979 Nov; 107(11):629-44. PubMed ID: 552154
[No Abstract] [Full Text] [Related]
22. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
23. Studies of serum complement in the hypocomplementaemic nephritides.
Williams DG; Peters DK; Fallows J; Petrie A; Kourilsky O; Morel-Maroger L; Cameron JS
Clin Exp Immunol; 1974 Nov; 18(3):391-405. PubMed ID: 4219908
[TBL] [Abstract][Full Text] [Related]
24. Plasma C3 and C4 concentrations in management of glomerulonephritis.
Cameron JS; Vick RM; Ogg CS; Seymour WM; Chantler C; Turner DR
Br Med J; 1973 Sep; 3(5882):668-72. PubMed ID: 4200478
[TBL] [Abstract][Full Text] [Related]
25. Plasma-exchange in immunologically mediated glomerular diseases.
D'Amico G; Sinico R; Fornasieri A; Ferrario F; Colasanti G; Paracchini ML; Fiorini GF
Ric Clin Lab; 1983; 13(1):141-57. PubMed ID: 6857095
[No Abstract] [Full Text] [Related]
26. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
27. The significance of C3 and C4 complement levels in lupus nephritis.
Levo Y; Pick AI
Int Urol Nephrol; 1974; 6(3-4):233-8. PubMed ID: 4549215
[No Abstract] [Full Text] [Related]
28. Characterization of mixed membranous and proliferative glomerulonephritis: recognition of three varieties.
Burkholder PM; Hyman LR; Krueger RP
Perspect Nephrol Hypertens; 1973; 1 Pt 1():557-89. PubMed ID: 4620927
[No Abstract] [Full Text] [Related]
29. Serum and glomerular complement in 205 cases of glomerulonephritis.
Durante A; Rovati C; di Belgiojoso GB; Minetti L
Proc Eur Dial Transplant Assoc; 1976; 12():189-96. PubMed ID: 935112
[TBL] [Abstract][Full Text] [Related]
30. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
[TBL] [Abstract][Full Text] [Related]
31. Dense deposit disease: a variant of membranoproliferative glomerulonephritis.
Habib R; Gubler MC; Loirat C; Mäiz HB; Levy M
Kidney Int; 1975 Apr; 7(4):204-15. PubMed ID: 1095806
[No Abstract] [Full Text] [Related]
32. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.
Robson MG; Cook HT; Botto M; Taylor PR; Busso N; Salvi R; Pusey CD; Walport MJ; Davies KA
J Immunol; 2001 Jun; 166(11):6820-8. PubMed ID: 11359841
[TBL] [Abstract][Full Text] [Related]
33. Glomerulonephritides and hypocomplementemia: pathophysiology and pathogenic implications.
Leibowitch J; Leveille M; Halwachs L; Wattel S
Adv Nephrol Necker Hosp; 1980; 9():295-314. PubMed ID: 6773316
[No Abstract] [Full Text] [Related]
34. Glomerulonephritis mediated by antibody to glomerular basement membrane. Immunological, clinical, and histopathological characteristics.
McPhaul JJ; Mullins JD
J Clin Invest; 1976 Feb; 57(2):351-61. PubMed ID: 56340
[TBL] [Abstract][Full Text] [Related]
35. Childhood nephritis.
McAdams AJ; McEnergy PT; Bove KE; West CD
Perspect Pediatr Pathol; 1973; 1():189-225. PubMed ID: 4788559
[No Abstract] [Full Text] [Related]
36. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-1976.
N Engl J Med; 1976 Jan; 294(2):100-5. PubMed ID: 1244490
[No Abstract] [Full Text] [Related]
37. The distribution and character of glomerular deposits in systemic lupus erythematosus.
Dujovne I; Pollak VE; Pirani CL; Dillard MG
Kidney Int; 1972 Jul; 2(1):33-50. PubMed ID: 4210771
[No Abstract] [Full Text] [Related]
38. Lupus nephritis: natural history and therapy.
Hecht B; Siegel NJ; Kashgarian M; Hayslett JP
Perspect Nephrol Hypertens; 1976; 3():21-41. PubMed ID: 175347
[No Abstract] [Full Text] [Related]
39. Immunopathological changes during immunosuppressive treatment of glomerulonephritis in systemic lupus erythematosus.
Munthe E; Brodwall EK; Oyri A; Natvig JB
Acta Med Scand; 1974 Oct; 196(4):291-9. PubMed ID: 4139879
[No Abstract] [Full Text] [Related]
40. The course of lupus nephritis: contribution of serial renal biopsies.
Morel-Maroger L; Méry JP; Droz D; Godin M; Verroust P; Kourilsky O; Richet G
Adv Nephrol Necker Hosp; 1976; 6():79-118. PubMed ID: 139084
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
